199 related articles for article (PubMed ID: 8605349)
1. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders.
Trentin L; Cerutti A; Zambello R; Sancretta R; Tassinari C; Facco M; Adami F; Rodeghiero F; Agostini C; Semenzato G
Blood; 1996 Apr; 87(8):3327-35. PubMed ID: 8605349
[TBL] [Abstract][Full Text] [Related]
2. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells.
Trentin L; Zambello R; Benati C; Cassatella M; Agostini C; Bulian P; Adami F; Carra G; Pizzolo G; Semenzato G
Cancer Res; 1992 Oct; 52(19):5223-8. PubMed ID: 1394125
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-15: a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes.
Trentin L; Zambello R; Facco M; Sancetta R; Agostini C; Semenzato G
Leuk Lymphoma; 1997 Sep; 27(1-2):35-42. PubMed ID: 9373194
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Facco M; Trentin L; Sancetta R; Tassinari C; Perin A; Milani A; Pizzolo G; Rodeghiero F; Agostini C; Meazza R; Ferrini S; Semenzato G
Blood; 1997 Jan; 89(1):201-11. PubMed ID: 8978293
[TBL] [Abstract][Full Text] [Related]
5. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders.
Trentin L; Zambello R; Agostini C; Siviero F; Adami F; Marcolongo R; Raimondi R; Chisesi T; Pizzolo G; Semenzato G
Blood; 1993 Feb; 81(3):752-8. PubMed ID: 8381309
[TBL] [Abstract][Full Text] [Related]
6. Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia.
Trentin L; Zambello R; Agostini C; Enthammer C; Cerutti A; Adami F; Zamboni S; Semenzato G
Blood; 1994 Dec; 84(12):4249-56. PubMed ID: 7994039
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of expression of interleukin-2 receptor beta chain (p70-75) on various leukemic cells.
Hoshino S; Oshimi K; Tsudo M; Miyasaka M; Teramura M; Masuda M; Motoji T; Mizoguchi H
Blood; 1990 Aug; 76(4):767-74. PubMed ID: 2383656
[TBL] [Abstract][Full Text] [Related]
8. Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells.
Schumann RR; Nakarai T; Gruss HJ; Brach MA; von Arnim U; Kirschning C; Karawajew L; Ludwig WD; Renauld JC; Ritz J; Herrmann F
Blood; 1996 Mar; 87(6):2419-27. PubMed ID: 8630406
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
Carlsson M; Tötterman TH; Rosén A; Nilsson K
Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
[TBL] [Abstract][Full Text] [Related]
10. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic analysis of hairy cell leukemia: "variant" cases express the interleukin-2 receptor beta chain, but not the alpha chain (CD25).
de Totero D; Tazzari PL; Lauria F; Raspadori D; di Celle PF; Carbone A; Gobbi M; Foa R
Blood; 1993 Jul; 82(2):528-35. PubMed ID: 8329708
[TBL] [Abstract][Full Text] [Related]
12. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA
J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571
[TBL] [Abstract][Full Text] [Related]
13. Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors.
Foa R; Fierro MT; Raspadori D; Bonferroni M; Cardona S; Guarini A; Tos AG; di Celle PF; Cesano A; Matera L
Blood; 1990 Oct; 76(7):1349-54. PubMed ID: 2207312
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion.
Francia di Celle P; Mariani S; Riera L; Stacchini A; Reato G; Foa R
Blood; 1996 May; 87(10):4382-9. PubMed ID: 8639799
[TBL] [Abstract][Full Text] [Related]
15. Origin of the soluble interleukin-2 receptor in the serum of patients with hairy cell leukemia.
Semenzato G; Trentin L; Zambello R; Agostini C; Bulian P; Siviero F; Ambrosetti A; Vinante F; Prior M; Chilosi M
Leukemia; 1988 Dec; 2(12):788-92. PubMed ID: 3264362
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
[TBL] [Abstract][Full Text] [Related]
17. Characterization of interleukin 2 receptors on B-cell chronic lymphocytic leukemia cells.
Tsilivakos V; Tsapis A; Kakolyris S; Iliakis P; Perraki M; Georgoulias V
Leukemia; 1994 Sep; 8(9):1571-8. PubMed ID: 8090033
[TBL] [Abstract][Full Text] [Related]
18. The IL-2 receptor complex: expression and function on normal and leukemic B cells.
de Totero D; Francia di Celle P; Cignetti A; Foa R
Leukemia; 1995 Sep; 9(9):1425-31. PubMed ID: 7658707
[TBL] [Abstract][Full Text] [Related]
19. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells.
Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V
Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
